Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus

Lupus

Volumn 22, Issue 5, 2013, Pages 422-430

  Kosinski, M ^a   Gajria, K ^b,d   Fernandes, A W ^b   Cella, D ^c  

^a QualityMetric Incorporated   (United States)

^b MEDIMMUNE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Shire Plc   (United States)

Author keywords

Fatigue; Functional Assessment of Chronic Illness Therapy (FACIT) scale; qualitative research; systemic lupus erythematosus

Indexed keywords

HYDROXYCHLOROQUINE SULFATE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DEMOGRAPHY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE SCALE; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; LISTLESSNESS; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FATIGUE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84875925232     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313476360     Document Type: Article

References (19)

1. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus. 2006 ; 15: 633-643
2. Tench CM, McCurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000 ; 39: 1249-1254
3. Miller-Keane, O'Toole M Miller-Keane Encyclopedia & Dictionary of Medicine, Nursing & Allied Health, 7th edn. Elsevier Health Sciences, Philadelphia, PA, USA ; 2005 :
4. US Department of Health and Human Services. Guidance for industry: Systemic lupus erythematosus - developing medical products for treatment. US Food and Drug Administration, www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm072063.pdf (2010, accessed 18 July 2012).
5. Measurement of fatigue in systemic lupus erythematosus: A systematic review. Arthritis Rheum. 2007 ; 57: 1348-1357
6. Cella D, Yount S, Sorensen M, et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005 ; 32: 811-819
7. Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res (Hoboken). 2011 ; 63 (Suppl 11). S263 - S286
8. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997 ; 13: 63-74
9. Goligher EC, Pouchot J, Brant R, et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 635-642
10. Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D. Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol. 2011 ; 38: 672-679
11. US Department of Health and Human Services. Patient-reported outcome measures: Use in medical product development to support labeling claims. US Food and Drug Administration, www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (2009, accessed 6 February 2013).
12. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1 - eliciting concepts for a new PRO instrument. Value Health. 2011 ; 14: 967-977
13. Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: Developing best practices based on science and experience. Qual Life Res. 2009 ; 18: 1263-1278
14. Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: Comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol. 2010 ; 37: 296-304
15. Broderick JE, Schneider S, Schwartz JE, Stone AA. Interference with activities due to pain and fatigue: Accuracy of ratings across different reporting periods. Qual Life Res. 2010 ; 19: 1163-1170
16. Broderick JE, Schwartz JE, Vikingstad G, et al. The accuracy of pain and fatigue items across different reporting periods. Pain. 2008 ; 139: 146-157
17. Martin M, Kosinski M, Bjorner JB, et al. Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale. Qual Life Res. 2007 ; 16: 647-660
18. Richardson A, Adner N, Nordstrom G. Persons with insulin-dependent diabetes mellitus: Acceptance and coping ability. J Adv Nurs. 2001 ; 33: 758-763
19. Gonzalez-Calvo J, Gonzalez VM, Lorig K. Cultural diversity issues in the development of valid and reliable measures of health status. Arthritis Care Res. 1997 ; 10: 448-456